Nifty Microcap 250 News and Updates

Keep track of all breaking news on Nifty Microcap 250 from all sources in a single place.

Load latest

Shakti Pumps (India) Ltd.

22 Jul 2024

912.15

-0.79%

Shakti Pumps Q1 result: Net profit jumps to Rs 93 cr, revenue up four-fold

Business Standard

Shakti Pumps on Monday said it has posted a manifold jump in its consolidated profit after tax to Rs 92.6 crore during the June 2024 quarter, on the back of higher revenues and healthy order book. It had clocked a Profit After Tax (PAT) of Rs 1 crore in the April-June quarter of the preceding fiscal, the company said in a statement. During the first quarter, the company's revenue from operations rose four-fold to Rs 567.6 crore from Rs 113.1 crore in the year-ago quarter. As of June 2024, the company had an order book of around Rs 2,000 crore, the statement said. "We reported an outstanding start to FY25, with the first quarter demonstrating robust revenue growth and enhanced profitability. Our performance is attributable to the accelerated execution of the existing orders in both domestic and export markets," Shakti Pumps (India) Ltd Chairman Dinesh Patidar said. The improvement in margins was achieved due to a decline in raw material prices, coupled with economies of scale resul

Shakti Pumps (India) Ltd. has lost -24.86% in the last 6 Months

Shakti Pumps (India) Ltd.

22 Jul 2024

912.15

-0.79%

Shakti Pumps (India) Results Earnings Call for Q1FY25

Conference Call with Shakti Pumps (India) Management and Analysts on Q1FY25 Performance and Outlook. Listen to the full earnings transcript.

audio

Thangamayil Jewellery Ltd.

22 Jul 2024

1904.50

-0.99%

Thangamayil Jewellery to spend 400 crore in FY25 on new stores

Business Line

The board has given approval to open new branches up to eight mid- and small-size outlets and one flagship' outlet in Chennai in FY25

Thangamayil Jewellery Ltd.'s price crossed below 50Day SMA today

Shoppers Stop Ltd.

22 Jul 2024

527.05

3.05%

Shoppers Stop Q1 Results Review - Demand Slowdown, Weak Same-Store Sales Growth Hurt Earnings: Motilal Oswal

NDTV Profit

The brokerage trims its estimates given the slowdown; however, they factor in Shoppers Stop's aggressive store expansion of Intune and expect good growth in the beauty segment.

Shoppers Stop Ltd. is trading at high day volume of 128.7K.

Shakti Pumps (India) Ltd.

22 Jul 2024

912.15

-0.79%

Shakti Pumps stock locks in 5% upper circuit post robust Q1 earnings

Business Standard

Shares of Shakti Pumps were locked in a 5 per cent upper circuit at Rs 4,095.10 per share on the BSE in Monday's intraday deals

Shakti Pumps (India) Ltd. has lost -24.86% in the last 6 Months

Rossari Biotech Ltd.

22 Jul 2024

703.30

0.16%

to see Rapid results content

Shakti Pumps (India) Ltd.

22 Jul 2024

912.15

-0.79%

to see Rapid results content

Kirloskar Pneumatic Company Ltd.

22 Jul 2024

1406.40

0.26%

to see Rapid results content

Zydus Wellness Ltd.

22 Jul 2024

2010.60

-0.42%

Zydus Lifesciences gets Mexican authority nod for cancer remedy biosimilar

Business Standard

Zydus Lifesciences Ltd on Monday said it has received marketing approval from the Mexican regulatory authority for its biosimilar product -- Bhava, used in the treatment of certain types of cancers. Mexican regulatory authority COFEPRIS (Federal Commission for the Protection Against Sanitary Risk), has granted marketing approval for Bhava, a Bevacizumab biosimilar and it will be marketed in different strengths of 100 mg/4 ml and 400 mg/16 ml, Zydus Lifesciences said in a regulatory filing. Bhava is used in the treatment of metastatic colorectal cancer (mCRC), non-squamous non-small cell lung cancer, metastatic breast cancer, glioblastoma, advanced and/or metastatic renal cell carcinoma and ovarian cancer patients, it added. Zydus Managing Director, Sharvil Patel said the approval granted by COFEPRIS is the company's first biosimilars for patients in Latin America. "To bring in greater access and affordability to patients battling critical ailments, we have been developing a pipelin